TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.